Predictive Value of [−2]proPSA‐Related Indices for Prostate Cancer Detection Years Before Prostate‐Specific Antigen Elevation: Insights From a Five‐Year Longitudinal Screening Cohort
The Prostate · 2026-08-02
DOI: 10.1002/pros.70232 ↗At a glance
Journal article in The Prostate, published online on 2026-08-02. Written by Yoshitaka Sekine and 11 co-authors. Institution: Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan. Major MEDLINE topics: Prostatic Neoplasms, Prostate-Specific Antigen, Early Detection of Cancer, Protein Precursors. 32 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background [‐2]proPSA(p2PSA)‐related indices have demonstrated diagnostic value for detecting prostate cancer (PC) in males with modest increases in prostate‐specific antigen levels (PSA) of < 10 ng/mL. However, the “leak point” of p2PSA level in the blood circulation before developing screen‐detectable PC remains uncertain. Therefore, this study evaluated the ability of p2PSA‐related indices in the years before considering conventional biopsy indications. Methods This case‐control study analyzed database and serum bank information from a population‐based screening cohort in Gunma Prefecture. The case group included 58 males diagnosed with PC due to increased PSA (4–10 ng/mL) followed serially for 5 years. The control group comprised 58 males without PC based on biopsy who were matched to the case group by adjusted PSA levels (± 2 ng/mL) and age (± 5 years) at the time of biopsy. p2PSA, free PSA, and PSA were measured from frozen serum samples from 0 to 5 years before biopsy. Results p2PSA‐to‐free PSA ratio (%p2PSA) and prostate health index (phi) were significantly higher in the case group than in the control group from five, three, and 3 years before biopsy, respectively. The areas under the receiver operating characteristic curve for predicting PC were 0.437 for PSA, 0.637 for phi, 0.663 for %p2PSA, and 0.618 for free PSA‐to PSA ratio (%fPSA) at 3 years before biopsy. Conclusions p2PSA‐related indices showed group‐level differences between future PC cases and matched controls before PSA exceeded conventional cut‐offs. These findings should be regarded as hypothesis‐generating and require validation in prospective studies before clinical application to risk‐stratified screening.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
- Department of Urology, Kurosawa Hospital, Takasaki, Japan.
ORCID profiles: Yoshitaka Sekine, Yuji Fujizuka, Akira Ohtsu, Yoshiyuki Miyazawa, Seiji Arai, Kazuto Ito, Kazuhiro Suzuki
Cite
APA
Sekine, Y., Fujizuka, Y., Nakazawa, S., Tsuji, Y., Ohtsu, A., Miyazawa, Y., Arai, S., Nomura, M., Koike, H., Matsui, H., Ito, K., & Suzuki, K. (2026). Predictive Value of [−2]proPSA‐Related Indices for Prostate Cancer Detection Years Before Prostate‐Specific Antigen Elevation: Insights From a Five‐Year Longitudinal Screening Cohort. The Prostate. https://doi.org/10.1002/pros.70232
Vancouver
Sekine Y, Fujizuka Y, Nakazawa S, Tsuji Y, Ohtsu A, Miyazawa Y, et al. Predictive Value of [−2]proPSA‐Related Indices for Prostate Cancer Detection Years Before Prostate‐Specific Antigen Elevation: Insights From a Five‐Year Longitudinal Screening Cohort. The Prostate. 2026. doi:10.1002/pros.70232
BibTeX
@article{Sekine2026,
author = {Sekine, Yoshitaka and Fujizuka, Yuji and Nakazawa, Syun and Tsuji, Yusuke and Ohtsu, Akira and Miyazawa, Yoshiyuki and Arai, Seiji and Nomura, Masashi and Koike, Hidekazu and Matsui, Hiroshi and Ito, Kazuto and Suzuki, Kazuhiro},
title = {Predictive Value of [−2]proPSA‐Related Indices for Prostate Cancer Detection Years Before Prostate‐Specific Antigen Elevation: Insights From a Five‐Year Longitudinal Screening Cohort},
journal = {The Prostate},
year = {2026},
doi = {10.1002/pros.70232}
}
EUVIMED